★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★

Checking

Stock Profile

DSM-Firmenich AG (DSFIR) Moat Analysis

DSM-Firmenich AG

DSFIR · Euronext Amsterdam

Market cap (USD)$19.8B
SectorMaterials
IndustryHousehold & Personal Products
CountryCH
Data as of
Moat score
68/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Request update

Spot something outdated? Send a quick note and source so we can refresh this profile.

Overview

DSM-Firmenich AG is a Swiss-incorporated ingredients company dual-listed on Euronext Amsterdam and SIX Swiss Exchange under DSFIR. Continuing operations comprise Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care; Animal Nutrition & Health is held for sale and reported as discontinued operations pending an expected end-2026 closing with CVC. The defensible segment advantages are concentrated in customer-specific co-creation and application work, Perfumery & Beauty's backward-integrated ingredient palette, Taste/Texture/Health portfolio breadth, regulated-product approvals in Health/Nutrition/Care, and ANH's premix-linked field-service network. Several broader innovation, patent, ecosystem, and analytics capabilities are not treated as moats without evidence that they create customer lock-in or an exclusionary choke point. Q1 2026 continuing operations delivered 4% like-for-like, volume-led sales growth, while reported sales fell 3% under currency and portfolio effects.

Primary segment

Perfumery & Beauty

Market structure

Oligopoly

Market share

HHI:

Coverage

4 segments · 8 tags

Updated 2026-07-11

Segments

Perfumery & Beauty

B2B fragrances, perfumery ingredients, and beauty ingredients

Revenue

30.1%

Structure

Oligopoly

Pricing

moderate

Share

Peers

GIVN.SWSY1.DEIFF

Taste, Texture & Health

B2B food & beverage flavors and ingredient solutions (taste, texture, functional ingredients)

Revenue

25.2%

Structure

Oligopoly

Pricing

moderate

Share

Peers

GIVN.SWSY1.DEIFFKYGA.IR

Health, Nutrition & Care

Nutrition and health ingredients & solutions (dietary supplements, early life nutrition, pharma, biomedical)

Revenue

16.8%

Structure

Competitive

Pricing

moderate

Share

Peers

IFFBAS.DELONN.SW

Animal Nutrition & Health

Animal nutrition ingredients, premixes, feed additives, and precision services

Revenue

27.9%

Structure

Competitive

Pricing

weak

Share

Peers

EVK.DEBAS.DEADM

Moat Claims

Perfumery & Beauty

B2B fragrances, perfumery ingredients, and beauty ingredients

Revenue share computed from 2025 segment net sales (EUR 3,760m) versus the four business-unit net sales total (EUR 12,495m), excluding the small Corporate reconciliation line. Source: Integrated Annual Report 2025 segment information.

Oligopoly

Supply Chain Control

Supply

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 1 of 5

Backwards-integrated ingredient portfolio (incl. proprietary 'captives') supports supply assurance and differentiated perfumery palettes.

Supply Chain Control moat: definition, examples, and stocks

Erosion risks

  • Regulatory restrictions on certain fragrance ingredients
  • Supply shocks in naturals and key chemical precursors
  • Large peers expand vertical integration or secure exclusive feedstocks

Leading indicators

  • Gross margin stability vs raw-material volatility
  • OTIF / service levels around peak demand
  • Mix shift toward proprietary ingredients and premium creations

Counterarguments

  • Large peers also have deep ingredient portfolios and vertical integration
  • Many aroma chemicals are widely available, limiting input exclusivity

Training Org Change Costs

Demand

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 3 of 5

Evidence

Evidence 2 of 5

Customer-intimacy and application/creation infrastructure embeds DSM-Firmenich into customer briefs; switching typically requires re-briefing, reformulation, testing, and re-approval.

Training Org Change Costs moat: definition, examples, and stocks

Erosion risks

  • AI-assisted formulation reduces reliance on supplier application expertise
  • Procurement-driven re-bids increase customer switching frequency
  • Growth of private label reduces willingness to pay for differentiated creations

Leading indicators

  • Major brief win-rate and renewal cadence
  • Customer retention and share-of-wallet
  • Innovation pipeline conversion to launches

Counterarguments

  • Large customers routinely multi-source and can re-tender fragrance briefs
  • Sensory equivalence work can enable switching over time

Taste, Texture & Health

B2B food & beverage flavors and ingredient solutions (taste, texture, functional ingredients)

Revenue share computed from 2025 segment net sales (EUR 3,146m) versus the four business-unit net sales total (EUR 12,495m), excluding the small Corporate reconciliation line. Source: Integrated Annual Report 2025 segment information.

Oligopoly

Training Org Change Costs

Demand

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 1 of 5

Co-creation tied to customers' specific recipes and matrices makes supplier swaps costly due to reformulation, sensory validation, and scale-up work.

Training Org Change Costs moat: definition, examples, and stocks

Erosion risks

  • Customer insourcing of application labs and reformulation work
  • Commoditization of some flavor/ingredient components
  • Regulatory-driven recipe changes increase re-tendering frequency

Leading indicators

  • Customer retention and net revenue retention in key accounts
  • Pipeline growth from concept-selling/cross-selling
  • Time-to-commercialization for new concepts

Counterarguments

  • Large food companies have significant internal R&D and can dual-source
  • In cost-focused categories, price competition can override switching frictions

Scope Economies

Supply

Strength

Strength 3 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 2 of 5

Broad portfolio across taste/texture/health enables concept-selling and cross-selling, improving customer coverage and lowering cost-to-serve per customer relationship.

Scope Economies moat: definition, examples, and stocks

Erosion risks

  • Portfolio complexity increases overhead and slows decision-making
  • Customers prefer best-of-breed point suppliers in niche categories

Leading indicators

  • Cross-sell rate (multi-solution penetration per customer)
  • SG&A efficiency (cost-to-serve) trend
  • Share of sales from new concepts and platforms

Counterarguments

  • Peers also offer broad portfolios; differentiation may be limited
  • Scope can dilute focus and innovation speed in fast-moving niches

Health, Nutrition & Care

Nutrition and health ingredients & solutions (dietary supplements, early life nutrition, pharma, biomedical)

Revenue share computed from 2025 segment net sales (EUR 2,102m) versus the four business-unit net sales total (EUR 12,495m), excluding the small Corporate reconciliation line. Source: Integrated Annual Report 2025 segment information.

Competitive

Compliance Advantage

Legal

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 3 of 5

Evidence

Evidence 1 of 5

Regulatory approvals and quality systems can create barriers to entry and favor scaled incumbents in regulated nutrition/pharma-adjacent ingredient markets.

Compliance Advantage moat: definition, examples, and stocks

Erosion risks

  • Regulatory changes increase costs or restrict ingredient claims
  • Quality incidents could damage trust and increase audits

Leading indicators

  • Number/pace of new regulatory approvals and registrations
  • Audit outcomes / quality metrics (deviations, recalls)
  • Pricing/margin stability in regulated subcategories

Counterarguments

  • Many regulated ingredients still face intense competition once approved
  • Compliance can become table-stakes rather than a differentiator

Animal Nutrition & Health

Animal nutrition ingredients, premixes, feed additives, and precision services

Revenue share computed from 2025 ANH net sales (EUR 3,487m) versus the four business-unit net sales total (EUR 12,495m), excluding the small Corporate reconciliation line. ANH is held for sale and classified as discontinued operations. The February 2026 agreement values the transaction at about EUR 2.2bn including an earnout of up to EUR 0.5bn; dsm-firmenich will retain 20% stakes in the two divested companies, and closing is expected at the end of 2026 subject to conditions.

Competitive

Service Field Network

Supply

Strength

Strength 4 of 5

Durability

Durability 2 of 3

Confidence

Confidence 4 of 5

Evidence

Evidence 1 of 5

Combining product sales with a premix network and precision/decision-support services increases stickiness and expands the value proposition beyond ingredients alone.

Service Field Network moat: definition, examples, and stocks

Erosion risks

  • Service offerings replicated by peers and integrators
  • Farm economics downturn reduces willingness to pay for services
  • Separation/carve-out disrupts service delivery or investment

Leading indicators

  • Attach rate of services to premix/product sales
  • Retention of premix accounts
  • Digital/precision user engagement and renewal metrics

Counterarguments

  • Many customers buy largely on price and availability in down-cycles
  • Integrators may develop internal nutrition teams and tools

Evidence

other

broadest, backwards-integrated portfolio in the industry, with a world-class palette, including captives

Direct statement of backward integration and proprietary inputs (captives).

other

fueled by customer intimacy

Customer intimacy is positioned as a core element of the operating model.

other

40 creation centers, and 78 application laboratories

Creation + application lab footprint supports co-creation and customer-specific formulation work.

other

unique ability to co-create Taste solutions with the optimal Food and Beverage matrix

Explicit claim of matrix-specific co-creation capability (a key switching-cost driver).

other

toolbox of ingredients and materials

Supports breadth of offerings that can enable cross-selling and scope economies.

Showing 5 of 8 sources.

Risks & Indicators

Erosion risks

  • Regulatory restrictions on certain fragrance ingredients
  • Supply shocks in naturals and key chemical precursors
  • Large peers expand vertical integration or secure exclusive feedstocks
  • AI-assisted formulation reduces reliance on supplier application expertise
  • Procurement-driven re-bids increase customer switching frequency
  • Growth of private label reduces willingness to pay for differentiated creations

Leading indicators

  • Gross margin stability vs raw-material volatility
  • OTIF / service levels around peak demand
  • Mix shift toward proprietary ingredients and premium creations
  • Major brief win-rate and renewal cadence
  • Customer retention and share-of-wallet
  • Innovation pipeline conversion to launches

Keep the research going

Created 2025-12-29
Updated 2026-07-11

More Rankings & Systems

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.